Maher Abdel-Sattar, PharmD
University of California, San Francisco
3333 California St.
Suite 420, Box 0613
San Francisco,
CA
USA
94143-0613
Papers:
3G-4
ERLOTINIB, AFATINIB, AND CISPLATIN/PEMETREXED FOR FIRST-LINE TREATMENT OF ADVANCED EGFR-MUTATION POSITIVE NON-SMALL CELL LUNG CANCER: VALUE-OF-INFORMATION ANALYSIS
Student?
yes
SMDM Member?
yes